CELESTICA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.36 CAD | +0.41% |
|
+5.94% | +52.95% |
| Apr. 26 | Celestica Downgraded to Neutral at CIBC, Price Target Raised to US$49 | MT |
| Apr. 26 | RBC Raises Celestica's Price Target to $53 From $47, Maintains Outperform Rating | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,064 | 1,041 | 1,391 | 1,374 | 3,485 | 5,152 | - | - |
| Enterprise Value (EV) 1 | 1,283 | 1,163 | 1,791 | 1,786 | 3,897 | 5,458 | 5,001 | 4,532 |
| P/E ratio | 15.6 x | 17.2 x | 13.6 x | 9.54 x | 14.4 x | 14.9 x | 15.3 x | 16.1 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.18 x | 0.18 x | 0.25 x | 0.19 x | 0.44 x | 0.56 x | 0.52 x | 0.47 x |
| EV / Revenue | 0.22 x | 0.2 x | 0.32 x | 0.25 x | 0.49 x | 0.6 x | 0.51 x | 0.42 x |
| EV / EBITDA | 4.77 x | 3.85 x | 5.35 x | 3.86 x | 7.04 x | 7.88 x | 6.79 x | 6.23 x |
| EV / FCF | 4.85 x | 6.16 x | 10.3 x | 9.45 x | 12.8 x | 18.7 x | 14.5 x | 7.34 x |
| FCF Yield | 20.6% | 16.2% | 9.75% | 10.6% | 7.82% | 5.35% | 6.89% | 13.6% |
| Price to Book | 0.8 x | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 128,424 | 129,056 | 124,712 | 122,107 | 119,041 | 118,806 | - | - |
| Reference price 2 | 8.285 | 8.063 | 11.15 | 11.25 | 29.27 | 43.36 | 43.36 | 43.36 |
| Announcement Date | 1/29/20 | 1/26/21 | 1/26/22 | 1/25/23 | 1/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 5,888 | 5,748 | 5,635 | 7,250 | 7,961 | 9,128 | 9,875 | 10,879 |
| EBITDA 1 | 268.9 | 301.9 | 334.7 | 462.7 | 553.2 | 692.4 | 736.2 | 727 |
| EBIT 1 | 158.1 | 199 | 233.9 | 358 | 445.2 | 557.8 | 605.2 | 653.5 |
| Operating Margin | 2.68% | 3.46% | 4.15% | 4.94% | 5.59% | 6.11% | 6.13% | 6.01% |
| Earnings before Tax (EBT) 1 | 99.8 | 90.2 | 136 | 203.6 | 306.6 | 422 | 426 | 419 |
| Net income 1 | 70.3 | 60.6 | 103.9 | 145.5 | 244.6 | 344.2 | 343.6 | 327 |
| Net margin | 1.19% | 1.05% | 1.84% | 2.01% | 3.07% | 3.77% | 3.48% | 3.01% |
| EPS 2 | 0.5300 | 0.4700 | 0.8200 | 1.180 | 2.030 | 2.905 | 2.827 | 2.700 |
| Free Cash Flow 1 | 264.5 | 188.6 | 174.6 | 189 | 304.6 | 291.9 | 344.3 | 617 |
| FCF margin | 4.49% | 3.28% | 3.1% | 2.61% | 3.83% | 3.2% | 3.49% | 5.67% |
| FCF Conversion (EBITDA) | 98.36% | 62.47% | 52.17% | 40.85% | 55.06% | 42.15% | 46.77% | 84.87% |
| FCF Conversion (Net income) | 376.24% | 311.22% | 168.05% | 129.9% | 124.53% | 84.79% | 100.21% | 188.69% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 1/29/20 | 1/26/21 | 1/26/22 | 1/25/23 | 1/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,512 | 1,567 | 1,717 | 1,923 | 2,043 | 1,838 | 1,939 | 2,043 | 2,140 | 2,209 | 2,248 | 2,293 | 2,375 | 2,435 | 2,491 |
| EBITDA 1 | 100.4 | 95.9 | 108.7 | 123.7 | 135.1 | 124.5 | 136.6 | 141.2 | 156 | 171.7 | 172.3 | 174 | 179.5 | 184.2 | 189.5 |
| EBIT 1 | 74.3 | 69.3 | 82.7 | 98.2 | 107.8 | 95.4 | 106.4 | 115.7 | 127.7 | 137.4 | 138.5 | 139.1 | 144.3 | 153.5 | 156.5 |
| Operating Margin | 4.91% | 4.42% | 4.82% | 5.11% | 5.28% | 5.19% | 5.49% | 5.66% | 5.97% | 6.22% | 6.16% | 6.06% | 6.07% | 6.3% | 6.28% |
| Earnings before Tax (EBT) 1 | - | - | - | - | - | - | 65.7 | 99.1 | 104.1 | 115.6 | 103 | 101 | 103 | 99 | 115 |
| Net income 1 | 31.9 | 21.8 | 35.6 | 45.7 | 42.4 | 24.7 | 55.5 | 80.2 | 84.2 | 101.7 | 80.05 | 79.15 | 81.35 | 79 | 92 |
| Net margin | 2.11% | 1.39% | 2.07% | 2.38% | 2.08% | 1.34% | 2.86% | 3.93% | 3.93% | 4.6% | 3.56% | 3.45% | 3.42% | 3.24% | 3.69% |
| EPS 2 | 0.2600 | 0.1700 | 0.2900 | 0.3700 | 0.3500 | 0.2000 | 0.4600 | 0.6700 | 0.7000 | 0.8500 | 0.6750 | 0.6650 | 0.6850 | 0.6600 | 0.7700 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 1/26/22 | 4/27/22 | 7/25/22 | 10/24/22 | 1/25/23 | 4/26/23 | 7/26/23 | 10/25/23 | 1/29/24 | 4/24/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 219 | 122 | 400 | 412 | 412 | 306 | - | - |
| Net Cash position 1 | - | - | - | - | - | - | 151 | 620 |
| Leverage (Debt/EBITDA) | 0.8152 x | 0.4044 x | 1.196 x | 0.8896 x | 0.7455 x | 0.4424 x | - | - |
| Free Cash Flow 1 | 265 | 189 | 175 | 189 | 305 | 292 | 344 | 617 |
| ROE (net income / shareholders' equity) | 5.32% | 9.16% | 11.4% | 14.9% | - | 18% | 18.2% | 15.5% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | 6.5% | 6.8% | 6.9% |
| Assets 1 | - | - | - | - | - | 5,296 | 5,053 | 4,739 |
| Book Value Per Share | 10.40 | - | - | - | - | - | - | - |
| Cash Flow per Share 2 | 1.790 | 2.040 | 1.790 | 3.660 | 3.570 | 4.530 | 4.930 | - |
| Capex 1 | 80.5 | 52.8 | 52.2 | 109 | 125 | 164 | 148 | 150 |
| Capex / Sales | 1.37% | 0.92% | 0.93% | 1.5% | 1.57% | 1.8% | 1.5% | 1.37% |
| Announcement Date | 1/29/20 | 1/26/21 | 1/26/22 | 1/25/23 | 1/29/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
43.36
USD
Average target price
24.31
USD
Spread / Average Target
-43.93%
EPS Revisions
- Stock Market
- Equities
- CLS Stock
- Financials Celestica
